Your browser doesn't support javascript.
loading
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND study.
Hua, Le H; Bar-Or, Amit; Cohan, Stanley L; Lublin, Fred D; Coyle, Patricia K; Cree, Bruce Ac; Meng, Xiangyi; Su, Wendy; Cox, Gina Mavrikis; Fox, Robert J.
Affiliation
  • Hua LH; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. Electronic address: hual@ccf.org.
  • Bar-Or A; Department of Neurology and the Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Cohan SL; Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, OR, USA.
  • Lublin FD; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Coyle PK; Department of Neurology, Stony Brook University, Stony Brook, NY, USA.
  • Cree BA; UCSF, Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
  • Meng X; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Su W; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Cox GM; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Fox RJ; Mellen Center for Multiple Sclerosis Treatment and Research Neurological Institute Cleveland Clinic, Cleveland, OH, USA.
Mult Scler Relat Disord ; 75: 104766, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37245350
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azetidines / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis Type of study: Clinical_trials Limits: Humans Language: En Journal: Mult Scler Relat Disord Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azetidines / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis Type of study: Clinical_trials Limits: Humans Language: En Journal: Mult Scler Relat Disord Year: 2023 Document type: Article